心室颤动的除颤治疗:进展与更新
本文聚焦心室颤动所致心脏骤停的除颤治疗,综述除颤技术演变、现代自动体外除颤器(AED)的技术特点、提高AED可及性与生存率的策略、辅助治疗以及植入式心律转复除颤器(ICD)或可穿戴心律转复除颤器(WCD)的应用。
要点
- 室颤所致心脏骤停可通过心肺复苏、除颤、复律、起搏及针对病因的治疗实现逆转。
- AED、ICD与WCD是可对可电击心律实施除颤的主要设备。
- 提高AED可及性是改善院外心脏骤停生存率的重要策略。
核心结论
- 本文总结心室颤动所致心脏性猝死除颤治疗的最新进展,涵盖除颤技术演变、AED技术特点、可及性策略、辅助治疗及ICD与WCD应用。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 院外心脏骤停患者多数存在冠状动脉疾病或事件前1小时内有症状。
- 心脏骤停可通过心肺复苏、除颤、复律、心脏起搏或针对基础疾病的治疗实现潜在逆转。
- 本文所述心脏性猝死限定为心室颤动所致心脏骤停,包括可被AED、ICD或WCD电击的心律。
临床怎么用
- 对室颤等可电击心律应尽早除颤,并联合心肺复苏及针对病因的治疗。
- 应关注提高AED可及性的策略,并合理使用ICD或WCD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiac arrest is defined as the termination of cardiac activity associated with loss of consciousness, of spontaneous breathing, and of circulation. Sudden cardiac arrest and sudden cardiac death (SCD) are terms often used interchangeably. Most patients with out-of-hospital cardiac arrest have shown coronary artery disease or symptoms during the hour before the event. Cardiac arrest is potentially reversible by cardiopulmonary resuscitation, defibrillation, cardioversion, cardiac pacing, or treatments targeted at the underlying disease (e.g., acute coronary occlusion). We restrict SCD hereafter to cardiac arrest due to ventricular fibrillation, including rhythms shockable by an automatic external defibrillator (AED), implantable cardioverter-defibrillator (ICD), or wearable cardioverter-defibrillator (WCD). We summarize the state of the art related to defibrillation in treating SCD, including a brief history of the evolution of defibrillation, technical characteristics of modern AEDs, strategies to improve AED access and increase survival, ancillary treatments, and use of ICDs or WCDs.
引用
- Nichol G, Sayre MR, Guerra F, et al. Defibrillation for Ventricular Fibrillation: A Shocking Update. J Am Coll Cardiol. 2017. PMID: 28911514. doi:10.1016/j.jacc.2017.07.778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。